Related Experiment Videos
[Changes in the blood coagulation system in pregnancy]
1Zentrum für Innere Medizin, Medizinische Klinik IV, Klinikstr. 36, 35385 Giessen. Bettins.Kemkes-Matthes@innere.med.uni-giessen.de
Zeitschrift Fur Kardiologie
|May 26, 2001
Summary
Pregnancy significantly alters the coagulation system, increasing clotting factors and decreasing protein S, which elevates the risk of blood clots. These changes contribute to a higher thromboembolic risk during pregnancy.
Area of Science:
- Hematology
- Obstetrics
- Physiology
Context:
- Pregnancy involves complex physiological changes impacting hemostasis.
- Elevated thromboembolic risk is a known complication during pregnancy.
Purpose:
- To elucidate the specific alterations in the coagulation system during pregnancy.
- To correlate these hemostatic changes with increased thromboembolic risk.
Summary:
- Pregnancy is characterized by increased coagulation factors and decreased levels of the inhibitor protein S, leading to a prothrombotic state.
- Activation markers such as prothrombin fragment F 1+2, beta-thromboglobulin, and D-dimer are elevated, indicating enhanced coagulation and fibrinolysis.
- These systemic hemostatic modifications are directly linked to the heightened risk of venous thromboembolism in pregnant individuals.
Impact:
- Provides a clearer understanding of pregnancy-associated hemostatic changes.
- Highlights the mechanisms underlying increased thromboembolic events in pregnancy.
- Informs clinical monitoring and potential preventative strategies for thromboembolism in pregnant patients.